Platelet function inhibitors

Citations 191-200 of 251 total displayed.

Past content (since Oct 2000):

Clinical Investigations and Reports
Randomized COMparison of Platelet Inhibition With Abciximab, TiRofiban and Eptifibatide During Percutaneous Coronary Intervention in Acute Coronary Syndromes: The COMPARE Trial: Wayne B. Batchelor, Thaddeus R. Tolleson, Yao Huang, Rhonda L. Larsen, R. Michael Mantell, Patricia Dillard, Marie Davidian, Daowen Zhang, Warren J. Cantor, Michael H. Sketch, Jr, E. Magnus Ohman, James P. Zidar, Daniel Gretler, Peter M. DiBattiste, James E. Tcheng, Robert M. Califf, and Robert A. Harrington
Circulation 2002;106:1470-1476; published online before print as doi:10.1161/01.CIR.0000029744.01096.1F [Abstract] [Full text]

Articles
Randomized COMparison of Platelet Inhibition With Abciximab, TiRofiban and Eptifibatide During Percutaneous Coronary Intervention in Acute Coronary Syndromes. The COMPARE Trial: Wayne B. Batchelor, Thaddeus R. Tolleson, Yao Huang, Rhonda L. Larsen, R. Michael Mantell, Patricia Dillard, Marie Davidian, Daowen Zhang, Warren J. Cantor, Michael H. Sketch, Jr, E. Magnus Ohman, James P. Zidar, Daniel Gretler, Peter M. DiBattiste, James E. Tcheng, Robert M. Califf, and Robert A. Harrington
Circulation published September 3, 2002, doi:10.1161/01.CIR.0000029744.01096.1F [Abstract]

Clinical Investigations and Reports Aspirin Plus Coumarin Versus Aspirin Alone in the Prevention of Reocclusion After Fibrinolysis for Acute Myocardial Infarction: Results of the Antithrombotics in the Prevention of Reocclusion In Coronary Thrombolysis (APRICOT)-2 Trial: Marc A. Brouwer, Paul J.P.C. van den Bergh, Wim R.M. Aengevaeren, Gerrit Veen, Hans E. Luijten, Don P. Hertzberger, Ad J. van Boven, Ralf P.J.W. Vromans, Gérard J.H. Uijen, and Freek W.A. Verheugt
Circulation 2002;106:659-665; published online before print as doi:10.1161/01.CIR.0000024408.81821.32 [Abstract] [Full text]

Current Perspectives
Platelet Glycoprotein IIb/IIIa Inhibitors: Recognition of a Two-Edged Sword?: Martin J. Quinn, Edward F. Plow, and Eric J. Topol
Circulation 2002;106:379-385, doi:10.1161/01.CIR.0000019581.22812.B2 [Full text]

Articles Aspirin Plus Coumarin Versus Aspirin Alone in the Prevention of Reocclusion After Fibrinolysis for Acute Myocardial Infarction. Results of the Antithrombotics in the Prevention of Reocclusion In COronary Thrombolysis (APRICOT)-2 Trial: Marc A. Brouwer, Paul J.P.C. van den Bergh, Wim R.M. Aengevaeren, Gerrit Veen, Hans E. Luijten, Don P. Hertzberger, Ad J. van Boven, Ralf P.J.W. Vromans, Gérard J.H. Uijen, and Freek W.A. Verheugt
Circulation published July 15, 2002, doi:10.1161/01.CIR.0000024408.81821.32 [Abstract]

Clinical Investigations and Reports
Abciximab Attenuates Coronary Microvascular Endothelial Dysfunction After Coronary Stenting: Eve D. Aymong, Michael J. Curtis, Mostafa Youssef, Michelle M. Graham, Lana Shewchuk, Wendy Leschuk, and Todd J. Anderson
Circulation 2002;105:2981-2985; published online before print as doi:10.1161/01.CIR.0000019905.18467.07 [Abstract] [Full text]

Clinical Investigations and Reports Impact of Different Platelet Glycoprotein IIb/IIIa Receptor Inhibitors Among Diabetic Patients Undergoing Percutaneous Coronary Intervention: Do Tirofiban and ReoPro Give Similar Efficacy Outcomes Trial (TARGET) 1-Year Follow-Up: Marco Roffi, David J. Moliterno, Bernhard Meier, Eric R. Powers, Cindy L. Grines, Peter M. DiBattiste, Howard C. Herrmann, Michel Bertrand, Katherine E. Harris, Laura A. Demopoulos, Eric J. Topol for the TARGET Investigators*
Circulation 2002;105:2730-2736; published online before print as doi:10.1161/01.CIR.0000018123.02672.C7 [Abstract] [Full text]

Articles
Abciximab Attenuates Coronary Microvascular Endothelial Dysfunction After Coronary Stenting: Eve D. Aymong, Michael J. Curtis, Mostafa Youssef, Michelle M. Graham, Lana Shewchuk, Wendy Leschuk, and Todd J. Anderson
Circulation published May 28, 2002, doi:10.1161/01.CIR.0000019905.18467.07 [Abstract]

Correspondence
Activating Effects of GPIIb/IIIa Blockers: An Intrinsic Consequence of Ligand- Mimetic Properties • Response: K. Peter, M. Schwarz, C. Bode, Andrew L. Frelinger, III, Mark I. Furman, Lori A. Krueger, Marc R. Barnard, and Alan D. Michelson
Circulation 2002;105:e180-181e, doi:10.1161/01.CIR.0000017280.72394.1F [Full text]

Basic Science Reports Functional Significance of Adenosine 5'-Diphosphate Receptor (P2Y₁₂) in Platelet Activation Initiated by Binding of von Willebrand Factor to Platelet GP Ib ${alpha}$ Induced by Conditions of High Shear Rate: Shinya Goto, Noriko Tamura, Koji Eto, Yasuo Ikeda, and Shunnosuke Handa
Circulation 2002;105:2531-2536; published online before print as doi:10.1161/01.CIR.0000016703.93845.AF [Abstract] [Full text]

Subspecialty Collections Home

Show Platelet function inhibitors
collections from other journals.